A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC)

被引:33
作者
Choi, See Min [1 ]
Choi, Don Kyoung [2 ]
Kim, Tae Heon [2 ]
Jeong, Byong Chang [2 ]
Seo, Seong Il [2 ]
Jeon, Seong Soo [2 ]
Lee, Hyun Moo [2 ]
Choi, Han-Yong [2 ]
Jeon, Hwang Gyun [3 ]
机构
[1] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Urol, Jinju, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst,Dept Urol, Seoul, South Korea
来源
PLOS ONE | 2015年 / 10卷 / 03期
关键词
RADIOGRAPHIC SIZE; KIDNEY VOLUME; MASS; DIFFERENTIATION; TREAT;
D O I
10.1371/journal.pone.0122019
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective To investigate the difference between preoperative radiologic tumor volume (RTV) and postoperative pathologic tumor volume (PTV) in patients who received nephrectomy for renal cell carcinoma (RCC). Materials and Methods We reviewed 482 patients who underwent preoperative computed tomography (CT) within 4 weeks before radical or partial nephrectomy for renal cell carcinoma. RTV measured by a three dimensional rendering program was compared with PTV (pi/6xheightxlengthxwidth) measured in surgical specimen according to pathologic tumor size and histologic subtype. Correlation of the inter-quartile range (IQR) of the RTV and Fuhrman nuclear grade was also investigated. Results There was a significant positive linear correlation between RTV and PTV (p<0.001, r = 0.911), and the mean RTV and mean PTV were not significantly different (79.0 vs 76.9cm(3), p = 0.393). For pathologic tumor size (PTS) <4cm, the mean RTV was larger than the mean PTV (10.9 vs 7.1cm(3), p<0.001). For a PTS of 4-7cm, the mean RTV was larger than the mean PTV (56.0 vs 44.7cm(3), p<0.001). However, for a PTS >= 7cm, there was no statistical difference between RTV and PTV (p>0.05). Among patients with clear cell RCC, the mean RTV was significantly larger than the mean PTV (p = 0.042), not for non-clear cell group (p = 0.055). As the quartile of the RTV increased, the Fuhrman grade also increased (p<0.001). Conclusions RTV was correlated with PTV and pathologic grade. RTV was larger than the PTV for a tumor size 7 cm or less or in clear cell RCC. RTV may be useful to measure tumor burden preoperatively.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma
    Dong, Wen
    Chen, Xiong
    Huang, Ming
    Chen, Xu
    Gao, Ming
    Ou, Dehua
    Li, Kaiwen
    Wang, Chenyang
    Wu, Shaoxu
    Liu, Hao
    Xie, Weibin
    Xie, Wenlian
    Campbell, Steven C.
    Lin, Tianxin
    Huang, Jian
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [23] Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma
    Wang, Chao
    Wang, Yuning
    Hong, Tianyu
    Ye, Jianqing
    Chu, Chuanmin
    Zuo, Li
    Zhang, Jing
    Cui, Xingang
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (03) : 932 - 951
  • [24] Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma
    Pecoraro, Angela
    Palumbo, Carlotta
    Knipper, Sophie
    Rosiello, Giuseppe
    Luzzago, Stefano
    Tian, Zhe
    Shariat, Shahrokh F.
    Saad, Fred
    Lavallee, Luke
    Briganti, Alberto
    Kapoor, Anil
    Fiori, Cristian
    Porpiglia, Francesco
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : E610 - E618
  • [25] BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation
    Wang, Lin
    Park, Paul
    Zhang, Huina
    La Marca, Frank
    Claeson, Amy
    Than, Khoi
    Rahman, Shayan
    Lin, Chia-Ying
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (08) : 1941 - 1950
  • [26] The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
    Wang, Gang
    Zhou, Xiaowan
    Guo, Zengli
    Huang, Nan
    Li, Juan
    Lv, Yanfang
    Han, Lulu
    Zheng, Wei
    Xu, Dandan
    Chai, Dafei
    Li, Huizhong
    Li, Liantao
    Zheng, Junnian
    CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 150 - 162
  • [27] Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma
    Muller, Kristen E.
    Tafe, Laura J.
    de Abreu, Francine B.
    Peterson, Jason D.
    Wells, Wendy A.
    Barth, Richard J.
    Marotti, Jonathan D.
    HUMAN PATHOLOGY, 2015, 46 (02) : 327 - 333
  • [28] Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth?
    Morgan, Veronica A.
    Parker, Christopher
    MacDonald, Alison
    Thomas, Karen
    deSouza, Nandita M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (03) : 620 - 628
  • [29] Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
    Remark, Romain
    Alifano, Marco
    Cremer, Isabelle
    Lupo, Audrey
    Dieu-Nosjean, Marie-Caroline
    Riquet, Marc
    Crozet, Lucile
    Ouakrim, Hanane
    Goc, Jeremy
    Cazes, Aurelie
    Flejou, Jean-Francois
    Gibault, Laure
    Verkarre, Virginie
    Regnard, Jean-Francois
    Pages, Olivier-Nicolas
    Oudard, Stephane
    Mlecnik, Bernhard
    Sautes-Fridman, Catherine
    Fridman, Wolf-Herman
    Damotte, Diane
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4079 - 4091
  • [30] Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus
    Schmeusser, Benjamin N.
    Midenberg, Eric
    Palacios, Arnold R.
    Ali, Adil A.
    Patil, Dattatraya H.
    Higgins, Michelle
    Nabavizadeh, Reza
    Croll, Benjamin
    Williams, Milton
    Sheehy, John
    Zheng, Bill
    Narayan, Vikram M.
    Joshi, Shreyas S.
    Ogan, Kenneth
    Psutka, Sarah P.
    Bilen, Mehmet A.
    Master, Viraj A.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (04) : 475 - +